The Wall Street Journal (7/20, Wang, Subscription Publication) reports that yesterday at the Alzheimer’s Association International Conference, researchers presented data from the Biocard study, a long-term study of people at higher risk for Alzheimer’s. As a result of this study, investigators now believe that six biomarkers considered together may predict future Alzheimer’s disease.
The AP (7/20, Neergaard) reports, “Tracking about 350 people starting in middle age,” investigators “found a combination of tests predicted development of mild cognitive impairment within five years.” In addition to presence of the ApoE4 gene, the tests “include a spinal tap to measure toxic levels of Alzheimer’s hallmark amyloid and tau proteins; MRI scans to detect shrinking brain regions; and two standard memory assessments.” As of right now, “the combination isn’t ready for doctors’ offices, but should help” pharmaceutical makers “tell who to enroll in early-stage treatment studies.”
Related Links:
— “Study Shows Promise in Detecting an Individual’s Likelihood of Developing Alzheimer’s,” Shirley S. Wang,